Safety campaign aims to eliminate abbreviations
In an effort to improve patient safety, a nationwide educational campaign was recently launched to encourage physicians, pharmacists, and others to spell out crucial medical terms. The initiative aims to eliminate commonly used abbreviations that can cause medication errors, according to American Medical News (7/17/2006).
In an effort to improve patient safety, a nationwide educational campaign was recently launched to encourage physicians, pharmacists, and others to spell out crucial medical terms. The initiative aims to eliminate commonly used abbreviations that can cause medication errors, according to American Medical News (7/17/2006).
The American Medical Association and Joint Commission on Accreditation of Healthcare Organizations already encourage physicians and others to avoid the use of abbreviations in written orders, telephone or verbal prescriptions, medication administration records, and other communications. Some of the abbreviations that physicians and others should spell out include:
The Food and Drug Administration in conjunction with the Institute of Safe Medication Practices launched the initiative in June. A list of error-prone abbreviations to avoid is available on the FDA Web site at http://www.fda.gov/cder/drug/mederrors or the ISMP Web site at http:// http://www.ismp.org/tools/errorproneabbreviations.pdf.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More
